$CNS Pharmaceuticals (CNSP.US)$ On July 29, 2024, CNS Pharm...
On July 29, 2024, CNS Pharmaceuticals, Inc. (the “Company”) entered into Exclusive License Agreement and Stock Purchase Agreement (collectively, the “Cortice Agreements”) with Cortice Biosciences, Inc. (“Cortice”) pursuant to which Cortice granted the Company an exclusive license to the intellectual property rights related to certain patents around the compound TPI 287 in the United States, Canada, Mexico and Japan.
免责声明:社区由Moomoo Technologies Inc.提供,仅用于教育目的。
更多信息
评论
登录发表评论
Lnova : 我想知道发行股票是否导致了下跌?这笔交易涉及超过60万只股票。还有今晚发布的这些新文件讨论了3000万股股票和0.0001的股票成本。我迷路了
lucky_farmer : 大吃一惊![晕 [晕]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Rafey Jan 楼主 : 卖出 0.0001 的股票是没有意义的,因为股票的价值显然要高得多。我们需要有人来翻译报告。
Lnova Rafey Jan 楼主 : 我知道对吧,这份报告太多了法律和财务方面的词汇,请有人帮忙翻译![安慰 [安慰]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)